BioSpectra has completed the successful manufacture of three “Parenteral Grade” Carbohydrates: D-Galactose, Sucrose and Trehalose Dihydrate. These high-purity excipients are being produced with Low Bioburden, Low Endotoxin specifications for further use in critical parenteral drug applications. These products are being manufactured at BioSpectra’s FDA registered and inspected, 150,000 square foot GMP facility located in Bangor PA, USA. BioSpectra exclusively manufactures in the USA, premium GMP pharmaceutical ingredients, GMP process chemicals and GMP compounded solutions and solvents.